publication venue for [Exploration and practice of post-marketing survival benefit evaluation of Chinese patent medicine for cancer].. 46:1980-1987. 2021
has subject area 1104 Complementary and Alternative Medicine (FoR) Medicinal & Biomolecular Chemistry (Science Metrix)